Revealed: Erythromelalgia Treatment Market Trajectory Promises Robust Expansion Through 2035
The Erythromelalgia Treatment Market is expected to witness substantial developments, with the market size projected to advance to USD 179.31 million by 2035. From a modest USD 82.26 million in 2024, this growth trajectory reflects a significant compound annual growth rate (CAGR) of 5.50%. This forecast indicates a growing recognition of erythromelalgia, a condition increasingly troubling...
0 Yorumlar 0 hisse senetleri 50 Views 0 önizleme